Position in NVS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$305,290
-$49,090 QoQ
Shares Held
1,948
-16.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,123
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MEYER HANDELMAN CO holds $288,153,320 across 11 Drug Manufacturers - General names. NVS ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
382,328 | $49,129,148 | |
| 2 | ABBV |
AbbVie Inc.
|
183,536 | $46,184,999 | |
| 3 | AMGN |
Amgen Inc
|
111,120 | $40,238,774 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
316,637 | $40,003,918 | |
| 5 | LLY |
ELI LILLY & Co
|
26,804 | $32,149,523 | |
| 6 | JNJ |
Johnson & Johnson
|
113,039 | $28,708,514 | |
| 7 | PFE |
Pfizer Inc
|
1,098,861 | $26,460,572 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
412,364 | $23,760,413 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $305,290 | 1,948 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $354,380 | 2,320 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||